Abstract Background: Colorectal cancer continues to be one of the most common causes of cancer death, and the poor survival rates and liver metastases at the time of diagnosis urgently need more effective strategy for colorectal cancer treatment. Methods: The activities of N-(5-bromopyridin-2-yl)-2-((6-(2-chloroacetamido)benzo[d]thiazol-2-yl)thio)acetamide (YLT205), which is a novel small molecule compound synthesized by us, were investigated using MTT Results: YLT205 induced apoptosis of human colorectal cell lines in a dose-dependent manner. The occurrence of apoptosis was associated with activation of caspases-9 and -3, down-regulation of Bcl-2 and up-regulation of Bax in HCT116 cells. Moreover, YLT205 disrupted mitochondrial membranes and induced the release of cytochrome c into cytosol. Impaired phosphorylation of p44/42 mitogen-activated protein kinase was also observed while the expression of phosphorylated protein kinase B (Akt) was not affected. Furthermore, in HCT116 and SW620 tumor-bearing nude mice models, YLT205 dose-dependently inhibited tumor growth without obvious adverse effects. Immunohistochemistry analyses revealed YLT205 also induced apoptosis and inhibited tumor cell proliferation in vivo. Conclusion: These studies suggested that YLT205 might be a potential drug candidate for human colorectal cancer therapy.
Introduction
Colorectal cancer (CRC) continues to be one of the most common causes of cancer death both in men and women, being responsible for about 10% of total cancer-related mortality [1] . According to the report, there were over 102,480 new diagnoses and 50,830 deaths only in the United States in 2013 [2] . Chemotherapy, radiotherapy and surgery are the mainly strategies for colorectal cancer treatment at present, but not yet satisfactory for poor survival rates and liver metastases at the time of diagnosis [3] . Therefore, more effective strategy for CRC treatment is still an urgent need. Recently, the treatment of CRC is mainly focused on the deregulation of cell proliferation and apoptosis [4, 5] .
Apoptosis (programmed cell death) plays an important role in the balance between cell proliferation and cell death, and the deregulation of the apoptosis can lead to diseases, such as cancer [6] . Targeting apoptosis is a promising strategy in anticancer drug discovery [4, 7] , for cancer cells are highly dependent on aberration of the apoptosis signaling pathways to stay alive, and cancers are often resistant to chemotherapeutic agents that primarily work by inducing apoptosis [8, 9] . Apoptosis signaling pathways can be divided into two pathways: cell death receptor-mediated extrinsic pathway and mitochondrial-mediated intrinsic pathway [10] . The intrinsic apoptosis pathway mainly act through mitochondria, and the important events include the loss of mitochondrial transmembrane potential, the release of cytochrome c, and the participation of pro-and anti-apoptotic Bcl-2 family proteins [11, 12] . Intracellular death signals, such as DNA damage, toxins or depletion of ATP, can induce the release of cytochrome c from the inner membrane of mitochondria, which can subsequently interact with the Apaf-1 and ATP, which binds to pro-caspase-9, resulting in the cleavage of pro-caspase-9 and activation the effector caspase-3 and/or caspase-7 [13] . In the extrinsic Fas binding) leads to caspase-8 activation, and then cleavage and activation of downstream effector caspases, such as caspase-3 and caspase-7, resulting in chromatin condensation, DNA laddering and formation of apoptosis [14] .
Our research group found a novel benzothiazole derivative, N-(5-bromopyridin-2-yl)-anti-proliferative activity and induced apoptosis in vitro [15] . In this investigation, we via the mitochondrial also inhibited tumor growth in vivo by inducing apoptosis without causing toxic effects. 
Materials and Methods

Drugs and regents
China) [15 1 H-NMR,
Clonogenic survival assay
For clonogenic survival assay, 400 to 1000 cells were seeded in a six-well plate, and treated with
Morphological analysis by Hoechst staining
Hoechst 33358 staining was used to detect morphological changes associated with apoptosis. After microscopy (Zeiss, Axiovert 200, Germany).
Analysis of apoptosis by Flow Cytometry (FCM)
performed and analyzed by FCM. Finally, the data was analyzed using Flow Jo software.
and detected by FCM as described previously [17] . Cell culture and drug treatment were done as described . Growth inhibition was calculated from the start of treatment by comparison of the change in tumor volume for vehicle and treated group as before [19] . [20] . Three tumors per group were analyzed.
Analysis of HCT116 cell apoptosis by Immunohistochemistry and TUNEL assay in vivo
Toxicity evaluation
etiological symptoms of the mice including mortality, body weight, diarrhea, anorexia and skin ulceration were monitored continuously [21] . Serological analysis, hematological analysis, and histological examination were carried out after dissection. Serological analysis and hematological analysis were detected by Hitachi respectively. Heart, liver, spleen, lung, and kidney of the mice were stained with hematoxylin and eosin
Statistical analysis
Statistical analyses were carried out in Microsoft Excel or GraphPad Prism. P values were calculated by unpaired t P < 0.05. Data are displayed as means±SD/SEM from three
Results
Effects of YLT205 on human cancer cells viability in vitro
50 values were expressed. MTT assay. Each point represents the mean±SD for at least 3 independent experiments (*p<0.05; **p<0.01; SW620 cells. (C) The percentage of inhibition in colony-forming assays was expressed using vehicle treated cells at 100%. Data are expressed as mean±SD for at least 3 independent experiments (*p<0.05; **p<0.01; ***p<0.001).
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Cellular Physiology and Biochemistry
Effects of YLT205 on apoptosis-related proteins related proteins were detected by Western blot, including caspase family proteins, Bcl-2 of caspase-3 and caspase-9. As shown in Fig. 5A , expression of pro-caspase-3 and proincluding Bcl-2 and Bax. Fig. 5D showed that the expression of Bcl-2 was decreased expression level, but there was no clearly change in the level of phosphorylated Akt. (Table 2) . Moreover, microscopic examination of heart, liver, spleen, lung and kidney revealed that there were no Discussion apoptosis in human colorectal adenocarcinoma cells via the mitochondrial apoptotic pathway in vitro and inhibited tumor growth in vivo.
There are two classic apoptotic pathways, including the extracellular pathway and the intracellular pathway. In both pathways, caspase-3 plays a central role [22] and can be activated by upstream effector proteins, such as caspase-9, which could arouse the activation of mitochondrial intrinsic pathway [23] . The cleavage of caspase-9 and caspase-3 via the mitochondrial intrinsic pathway. In order In the intrinsic apoptotic pathway, many important events are closely related with the mitochondria, including the disruption of the mitochondrial transmembrane potential and the induction release of cytochrome c [10, 11] . In general, cytochrome c is localized in the mitochondrial membrane and would be released into the cytosol when intrinsic apoptosis downstream caspase-3 to initiate apoptosis [24] . In this study, we observed substantial Bcl-2 family is the center regulator in mitochondrial apoptosis pathway, and this family includes the anti-apoptotic Bcl-2 and pro-apoptotic Bax [12] , increasing in pro-apoptotic protein but decreasing in anti-apoptotic protein would stimulate the release of cytochrome c [25] . In our study, anti-apoptotic protein Bcl-2 was down-regulated while pro-apoptotic the change of the Bcl-2 family proteins is involved in the release of cytochrome c and may 2 play important roles in promoting cell proliferation and modulating cancer prevention and Furthermore, tumor growth inhibition in vivo was evaluated in tumor-bearing nude the inhibitory rate of 68.8% and 51.3% in human colon cancer SW620 and HCT116 models, in vitro, but also had an effective inhibition of tumor growth in vivo without causing obvious toxicities.
colon cancer growth both in vitro and in vivo, and induce human colon cancer cells apoptosis via mitochondrial intrinsic pathway. The mechanism of apoptosis was related to down regulation of Bcl-2 and conversely up regulation of Bax, along with the disruption of mitochondrial membrane, followed by release of cytochrome c from mitochondria to cytosol, showed antitumor activities in the colon cancer xenograft in vivo with no obvious toxicity, while its anti-tumor activities in other cancer types and the more precise mechanisms are still needed in future study.
